Stockscreener 앱 받기
19.95
1.73%
0.34
시간 외 거래:
19.95
전일 마감가:
$19.61
열려 있는:
$19.61
하루 거래량:
195.60K
Relative Volume:
1.21
시가총액:
$284.72M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.95%
1개월 성능:
-6.99%
6개월 성능:
+17.98%
1년 성능:
-41.97%
1일 변동 폭
$19.58
$20.66
1주일 범위
$18.39
$20.66
52주 변동 폭
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
명칭
Neurogene Inc
전화
(877) 237-5020
주소
535 W 24TH STREET, NEW YORK
NGNE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
19.95 | 279.87M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Craig Hallum | Buy |
| 2025-05-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-06-11 | 개시 | Robert W. Baird | Outperform |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2024-03-21 | 개시 | William Blair | Outperform |
| 2024-01-08 | 개시 | H.C. Wainwright | Buy |
| 2024-01-05 | 개시 | Stifel | Buy |
| 2024-01-04 | 개시 | TD Cowen | Outperform |
모두보기
Neurogene Inc 주식(NGNE)의 최신 뉴스
What’s the recovery path for long term holders of Neurogene Inc.July 2025 WrapUp & Long-Term Safe Return Strategies - Newser
What earnings revisions data tells us about Neurogene Inc.July 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
Does Neurogene Inc. stock have upside surprise potentialJuly 2025 Gainers & Reliable Volume Spike Alerts - خودرو بانک
27,482 Shares in Neurogene Inc. $NGNE Bought by Nuveen LLC - Defense World
What are Neurogene Inc.’s recent SEC filings showingPortfolio Value Report & Safe Capital Growth Stock Tips - خودرو بانک
Is Neurogene Inc. forming bullish engulfing patternsJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
Chart based exit strategy for Neurogene Inc.Market Volume Report & Technical Analysis for Trade Confirmation - Newser
Will Neurogene Inc. stock recover after recent drop2025 Major Catalysts & Daily Volume Surge Trade Alerts - Newser
Neurogene's Strategic Use of Inducement Grants to Fuel Growth and Innovation in Gene Therapy - AInvest
Neurogene announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Is Neurogene Inc. currently under institutional pressureExit Point & Accurate Entry and Exit Point Alerts - خودرو بانک
Is Neurogene Inc. stock reversal real or fakeEarnings Beat & Target Return Focused Picks - Newser
How sentiment analysis helps forecast Neurogene Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - Newser
Charles Schwab Investment Management Inc. Buys 3,652 Shares of Neurogene Inc. $NGNE - Defense World
Should you hold or exit Neurogene Inc. nowStock Surge & AI Forecasted Entry/Exit Points - Newser
What technical models suggest about Neurogene Inc.’s comebackJuly 2025 Update & Daily Price Action Insights - Newser
Is Neurogene Inc. a potential multi bagger2025 Growth vs Value & Fast Moving Stock Watchlists - خودرو بانک
Rare Disease Therapy Approvals By FDA Speed Up Via New ProcessNeurogene (NASDAQ:NGNE) - Benzinga
What’s the fair value of Neurogene Inc. stockJuly 2025 Update & Safe Investment Capital Preservation Plans - خودرو بانک
Neurogene Inc. Stock Lags Behind Sector BenchmarksJuly 2025 Sentiment & Capital Efficient Trade Techniques - beatles.ru
Why Neurogene Inc. stock attracts strong analyst attentionWeekly Stock Report & Short-Term High Return Ideas - Newser
Applying Elliott Wave Theory to Neurogene Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - Newser
How to manage a losing position in Neurogene Inc.2025 Institutional Moves & Safe Swing Trade Setup Alerts - Newser
Neurogene Inc. stock chart pattern explained2025 Analyst Calls & Precise Buy Zone Tips - Newser
Can Neurogene Inc. reach all time highs this yearTrade Risk Assessment & Stock Portfolio Risk Management - خودرو بانک
How to recover losses in Neurogene Inc. stockEarnings Overview Summary & Daily Profit Maximizing Tips - Newser
Using economic indicators to assess Neurogene Inc. potentialDividend Hike & AI Forecast for Swing Trade Picks - Newser
What is Neurogene Inc.’s valuation compared to sector2025 Key Lessons & Long-Term Growth Portfolio Plans - خودرو بانک
Using data models to predict Neurogene Inc. stock movementQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
Is Neurogene Inc. forming a bottoming baseJuly 2025 Decliners & Daily Stock Trend Reports - Newser
Using Ichimoku Cloud for Neurogene Inc. technicalsMarket Risk Analysis & Scalable Portfolio Growth Methods - Newser
How institutional ownership impacts Neurogene Inc. stockPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Order flow analysis tools used on Neurogene Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Wellington Management Group LLP Buys 12,704 Shares of Neurogene Inc. $NGNE - Defense World
What momentum shifts mean for Neurogene Inc.July 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
Is Neurogene Inc. a play on infrastructure spendingQuarterly Investment Review & AI Based Trade Execution Alerts - خودرو بانک
What earnings revisions data tells us about Neurogene IncQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Quantitative breakdown of Neurogene Inc. recent moveLayoff News & Weekly Top Stock Performers List - Newser
Neurogene Inc (NGNE) 재무 분석
Neurogene Inc (NGNE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):